Gauvin, C.; Krishnan, V.; Kaci, I.; Tran-Thanh, D.; Bédard, K.; Albadine, R.; Leduc, C.; Gaboury, L.; Blais, N.; Tehfe, M.;
et al. Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC. Curr. Oncol. 2021, 28, 593-605.
https://doi.org/10.3390/curroncol28010059
AMA Style
Gauvin C, Krishnan V, Kaci I, Tran-Thanh D, Bédard K, Albadine R, Leduc C, Gaboury L, Blais N, Tehfe M,
et al. Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC. Current Oncology. 2021; 28(1):593-605.
https://doi.org/10.3390/curroncol28010059
Chicago/Turabian Style
Gauvin, Camille, Vimal Krishnan, Imane Kaci, Danh Tran-Thanh, Karine Bédard, Roula Albadine, Charles Leduc, Louis Gaboury, Normand Blais, Mustapha Tehfe,
and et al. 2021. "Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC" Current Oncology 28, no. 1: 593-605.
https://doi.org/10.3390/curroncol28010059
APA Style
Gauvin, C., Krishnan, V., Kaci, I., Tran-Thanh, D., Bédard, K., Albadine, R., Leduc, C., Gaboury, L., Blais, N., Tehfe, M., Routy, B., & Florescu, M.
(2021). Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC. Current Oncology, 28(1), 593-605.
https://doi.org/10.3390/curroncol28010059